Evaluation of a Marine OXYgen Carrier: HEMO2Life® for hypOthermic Kidney Graft Preservation, Before Transplantation (OXYOP)
Condition(s):End Stage Renal DiseasesLast Updated:March 19, 2018Completed
Hide Studies Not Open or Pending
Condition(s):End Stage Renal DiseasesLast Updated:March 19, 2018Completed
Condition(s):End Stage Renal Disease on DialysisLast Updated:September 20, 2019Unknown status
Condition(s):End Stage Renal Disease (ESRD)Last Updated:January 19, 2017Completed
Condition(s):Hypertension, RenalLast Updated:February 17, 2021Completed
Condition(s):Kidney TransplantationLast Updated:January 22, 2024Suspended
Condition(s):End Stage Renal DiseaseLast Updated:December 20, 2023Completed
Condition(s):End Stage Renal Disease; Left Ventricular HypertrophyLast Updated:November 4, 2016Completed
Condition(s):End-stage Renal DiseaseLast Updated:June 5, 2012Completed
Condition(s):End-stage Renal DiseaseLast Updated:February 26, 2024Enrolling by invitation
Condition(s):End Stage Renal DiseaseLast Updated:July 18, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.